Strategic Fluorination to Achieve a Potent, Selective, Metabolically-Stable, and Orally-Bioavailable Inhibitor of CSNK2.
Authors:
- Han Wee OngHOHan Wee Ong
- Xuan YangXYXuan Yang
- Jeffery SmithJSJeffery Smith
- Sharon Taft-BenzSTSharon Taft-Benz
- Stefanie HowellSHStefanie Howell
- Rebekah DickmanderRDRebekah Dickmander
- Tammy HavenerTHTammy Havener
- Marcia SandersMSMarcia Sanders
- Jason BrownJBJason Brown
- Rafael CouñagoRCRafael Couñago
- Edcon ChangECEdcon Chang
- Andreas KrämerAKAndreas Krämer
Preprint
- 22 July 2024
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
The host kinase casein kinase 2 (CSNK2) has been proposed to be an antiviral target against β-coronaviral infection. To pharmacologically validate CSNK2 as a drug target in vivo, potent and selective CSNK2 inhibitors with good pharmacokinetic properties are required. Inhibitors based on the pyrazolo[1,5-a]pyrimidine scaffold possess outstanding potency and selectivity for CSNK2, but bioavailability and metabolic stability were often challenging. By strategically installing a fluorine atom on an electron-rich phenyl ring of a previously characterized inhibitor 1, we discovered compound 2 as a promising lead compound with improved in vivo metabolic stability. Compound 2 maintained excellent cellular potency against CSNK2, submicromolar antiviral potency, favorable solubility, and was remarkably selective for CSNK2 when screened against 192 kinases across the human kinome. We additionally present a co-crystal structure to support its on-target binding mode. In vivo, compound 2 was orally bioavailable, and demonstrated modest and transient inhibition of CSNK2, although antiviral activity was not observed, possibly attributed to its lack of prolonged CSNK2 inhibition.Keywords
All Related Versions
This publication has 36 references indexed in Scilit:
- Identification of 4-(6-((2-methoxyphenyl)amino)pyrazin-2-yl)benzoic acids as CSNK2A inhibitors with antiviral activity and improved selectivity over PIM3Bioorganic & Medicinal Chemistry Letters, 2024
- Host directed therapies: COVID-19 and beyondCurrent Research in Pharmacology and Drug Discovery, 2021
- Anti–SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology ConsiderationsCPT: Pharmacometrics & Systems Pharmacology, 2021
- Development of a potent and selective chemical probe for the pleiotropic kinase CK2Cell Chemical Biology, 2021
- Trends and strategies to combat viral infections: A review on FDA approved antiviral drugsInternational Journal of Biological Macromolecules, 2021
- Optimization of pyrazolo[1,5-a]pyrimidines lead to the identification of a highly selective casein kinase 2 inhibitorEuropean Journal of Medicinal Chemistry, 2020
- A Mouse-Adapted SARS-CoV-2 Induces Acute Lung Injury and Mortality in Standard Laboratory MiceCell, 2020
- Medicinal chemistry strategies toward host targeting antiviral agentsMedicinal Research Reviews, 2020
- Coral: Clear and Customizable Visualization of Human Kinome DataCell Systems, 2018
- Family Coronaviridae2017